Meta-analysis of summary survival curve data

被引:73
作者
Arends, Lidia R. [1 ]
Hunink, M. G. Myriam [1 ,2 ,3 ]
Stijnen, Theo [1 ]
机构
[1] Erasmus MC, Univ Med Ctr Rotterdam, Dept Epidemiol & Biostat, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus MC, Univ Med Ctr Rotterdam, Dept Radiol, NL-3000 CA Rotterdam, Netherlands
[3] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA
关键词
meta-analysis; time to event; multivariate random effects model;
D O I
10.1002/sim.3311
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The use of standard univariate fixed- and random-effects models in meta-analysis has become well known in the last 20 years. However, these models are unsuitable for meta-analysis of clinical trials that present multiple survival estimates (usually illustrated by a survival curve) during a follow-up period. Therefore, special methods are needed to combine the survival curve data from different trials in a meta-analysis. For this purpose, only fixed-effects models have been suggested in the literature. In this paper, we propose a multivariate random-effects model for joint analysis of survival proportions reported at multiple time points and in different studies, to be combined in a meta-analysis. The model could be seen as a generalization of the fixed-effects model of Dear (Biometrics 1994; 50:989-1002). We illustrate the method by using a simulated data example as well as using a clinical data example of meta-analysis with aggregated survival curve data. All analyses can be carried out with standard general linear MIXED model software. Copyright (c) 2008 John Wiley & Sons, Ltd.
引用
收藏
页码:4381 / 4396
页数:16
相关论文
共 31 条
[21]   ASSESSMENT OF THE EFFICACY AND SAFETY OF ANTIARRHYTHMIC THERAPY FOR CHRONIC ATRIAL-FIBRILLATION - OBSERVATIONS ON THE ROLE OF TRIAL DESIGN AND IMPLICATIONS OF DRUG-RELATED MORTALITY [J].
REIMOLD, SC ;
CHALMERS, TC ;
BERLIN, JA ;
ANTMAN, EM .
AMERICAN HEART JOURNAL, 1992, 124 (04) :924-931
[22]   Investigating trial and treatment heterogeneity in an individual patient data meta-analysis of survival data by means of the penalized maximum likelihood approach [J].
Rondeau, V. ;
Michiels, S. ;
Liquet, B. ;
Pignon, J. P. .
STATISTICS IN MEDICINE, 2008, 27 (11) :1894-1910
[23]   A general framework for random effects survival analysis in the cox proportional hazards setting [J].
Sargent, DJ .
BIOMETRICS, 1998, 54 (04) :1486-1497
[24]  
SHORE T, 1990, CANCER, V65, P1155, DOI 10.1002/1097-0142(19900301)65:5<1155::AID-CNCR2820650521>3.0.CO
[25]  
2-7
[26]   Advanced methods in meta-analysis: multivariate approach and meta-regression [J].
van Houwelingen, HC ;
Arends, LR ;
Stijnen, T .
STATISTICS IN MEDICINE, 2002, 21 (04) :589-624
[27]   A META-ANALYSIS OF PROGNOSTIC FACTORS IN ADVANCED OVARIAN-CANCER WITH MEDIAN SURVIVAL AND OVERALL SURVIVAL (MEASURED WITH THE LOG (RELATIVE RISK)) AS MAIN OBJECTIVES [J].
VOEST, EE ;
VANHOUWELINGEN, JC ;
NEIJT, JP .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (04) :711-720
[28]  
VOKO Z, 2000, ETIOLOGY PREVENTION
[29]   A GENERAL PARAMETRIC APPROACH TO THE METAANALYSIS OF RANDOMIZED CLINICAL-TRIALS [J].
WHITEHEAD, A ;
WHITEHEAD, J .
STATISTICS IN MEDICINE, 1991, 10 (11) :1665-1677
[30]   Individual patient data meta-analysis of randomized anti-epilepatic drug monotherapy trials [J].
Williamson, PR ;
Marson, AG ;
Tudur, C ;
Hutton, JL ;
Chadwich, D .
JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2000, 6 (02) :205-214